Malignant pancreatic neoplasm
Therapeutic area
Gastroenterology
Rare disease
No
- Definition
- A malignant neoplasm involving the pancreas.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Malignant pancreatic neoplasm
- Therapeutic area
- Gastroenterology
- malignant pancreatic neoplasm
- pancreas neoplasm
- cancer of pancreas
- malignant neoplasm of pancreas
- malignant neoplasm of the pancreas
- malignant pancreas neoplasm
- malignant pancreatic neoplasm
- pancreas cancer
- pancreatic cancer
- pancreatic tumour
- Severity
- Severe
- Endocrinology
- Gastroenterology
- Oncology
- MONDO ID
- MONDO:0009831
- Parent condition
- MONDO:0002516
Related records
Broader conditions (14)
- Cancer
- Cancer or benign tumor
- Digestive system cancer
- Digestive system disorder
- Digestive system neoplasm
- Disease
- Disease by body system or component
- Disease by etiologic mechanism
- Endocrine system disorder
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
- Pancreas disorder
- Pancreatic neoplasm
Narrower conditions (37)
- Colloid carcinoma of the pancreas
- Exocrine pancreatic carcinoma
- Familial pancreatic carcinoma
- Malignant exocrine pancreas neoplasm
- Mixed ductal-endocrine carcinoma of pancreas
- Mucinous pancreas adenocarcinoma
- Pancreas lymphoma
- Pancreas sarcoma
- Pancreatic acinar cell carcinoma
- Pancreatic acinar cell cystadenocarcinoma
- Pancreatic adenocarcinoma
- Pancreatic adenosquamous carcinoma
- Pancreatic carcinoma with mixed differentiation
- Pancreatic cystadenocarcinoma
- Pancreatic ductal adenocarcinoma
- Pancreatic endocrine carcinoma
- Pancreatic foamy gland adenocarcinoma
- Pancreatic intraductal papillary-mucinous carcinoma
- Pancreatic intraductal papillary-mucinous neoplasm
- Pancreatic intraductal papillary-mucinous neoplasm with an associated invasive carcinoma
Trials (473)
- "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures
- 18F-Fluoroazomycin Arabinoside PET-CT in Diagnosing Solid Tumors in Patients
- 9-ING-41 in Patients With Advanced Cancers
- A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
- A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain
- A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
- A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
- A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma
- A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer
- A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
- A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer
- A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies
- A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers
- A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
- A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.
- A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
- A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
- A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients
- A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
- A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy
Approved drugs (3)
- Gemcitabine hydrochloride
- Irinotecan hydrochloride
- Paclitaxel
Drugs in development (118)
- ABGN-107 Phase 1
- Adagrasib Phase 1
- Adebrelimab Phase 2
- Adenosine diphosphate Phase 1
- Albumin human Phase 3
- Algenpantucel-L Phase 3
- Antroquinonol Phase 2
- APG-1387 Phase 1
- Apricoxib Phase 2
- Archexin Phase 2
- ASG-5ME Phase 1
- Atezolizumab Phase 2
- Cabiralizumab Phase 2
- Cabozantinib Phase 2
- Capecitabine Phase 3
- Catequentinib Phase 2
- Certepetide Phase 1
- Cisplatin Phase 3
- Clopidogrel Phase 3
- Conteltinib Phase 1
Other linked drugs (25)
- Aglatimagene besadenovec
- Anamorelin hydrochloride
- AR-20.5
- Avasopasem manganese
- Bazedoxifene
- Bentiromide
- Brivudine
- Bupivacaine
- Docetaxel
- Ibrilatazar
- LMB-100
- Losartan
- Misetionamide
- Pelareorep
- Racemetyrosine
- Salirasib
- Secretin synthetic human
- Selpercatinib
- Streptozocin
- Tipifarnib